Preventing or treating anti-EGFR related skin rash with antibiotics? - Wikidata - awgldk - TriplyDB

Preventing or treating anti-EGFR related skin rash with antibiotics?

Preventing or treating anti-EGFR related skin rash with antibiotics?

http://www.wikidata.org/entity/Q42398733

about

Cutaneous Toxicities of Molecular Targeted Therapies.

P2860

Q41541640-DF2C0A97-7016-4AFE-916D-A5B737E4E4A1

P2860

Preventing or treating anti-EGFR related skin rash with antibiotics?

http://www.wikidata.org/entity/Q42398733

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Preventing or treating anti-EGFR related skin rash with antibiotics?

@en

Preventing or treating anti-EGFR related skin rash with antibiotics?

@nl

type

label

Preventing or treating anti-EGFR related skin rash with antibiotics?

@en

Preventing or treating anti-EGFR related skin rash with antibiotics?

@nl

prefLabel

Preventing or treating anti-EGFR related skin rash with antibiotics?

@en

Preventing or treating anti-EGFR related skin rash with antibiotics?

@nl

P1433

Q42398733-0CDE57F8-438D-47FA-8D19-1BF609B2FF7D

P1476

Q42398733-7BE3FD02-F1AB-4E6A-8774-39DA0F379B58

P2093

Q42398733-0A84B232-8331-4D42-ACC1-FECC34FC2FA2

Q42398733-5D771432-7D03-4DB2-99E0-2950AEB88232

Q42398733-C06FBD06-78D6-48D3-82F5-4F4D1091204A

P2860

Q42398733-01EEE42C-C1E3-412D-995F-34BC1B5D221D

Q42398733-1CCFD76E-0245-48D6-8415-132125F17B9A

Q42398733-21D9CA6F-7DEE-4986-B2F0-C38AB2CED82A

Q42398733-28F1DBA4-368F-48EB-AE38-E45992DCB4EA

Q42398733-38F76618-D3D1-44FA-B9F3-A16C8868BB19

Q42398733-567E8CD9-F3CE-4514-A698-102AB4190076

Q42398733-67ACF4BE-53AD-46CA-963A-D68B985F3B4E

Q42398733-70C2BC57-DCA8-4D07-A648-EDAD84FF98C4

Q42398733-7935A661-C515-4CC8-BD3F-A62F4872E2BE

P304

Q42398733-3E7F8648-2E2D-458C-A8DC-64908C972013

P31

Q42398733-BC019A50-60F7-481E-82C2-584769B677EE

Q42398733-a13e2dee-3c72-4c14-8731-f6cb79c3514c

P356

Q42398733-27AC01B7-4B93-4F54-A87C-217C1F0EAA56

P433

Q42398733-99286283-CDEF-4359-9D4D-37DC3E76A896

P478

Q42398733-DE4C8882-E340-42EC-A6CA-7535AFBB44EB

P577

Q42398733-9F724253-70B3-485B-9470-96F0D2DC7824

P698

Q42398733-DDD7C146-B2E8-4350-B92F-76241092A199

P932

Q42398733-8668E887-3E13-4893-AADB-BA6F747C2752

P356

P1433

Annals of translational medicine

P1476

Preventing or treating anti-EGFR related skin rash with antibiotics?

@en

P2093

Fausto Petrelli

http://www.w3.org/2001/XMLSchema#string

Karen Borgonovo

http://www.w3.org/2001/XMLSchema#string

Sandro Barni

http://www.w3.org/2001/XMLSchema#string

P2860

Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-Emptive Skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer

Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation.

Antibiotic prophylaxis for skin toxicity induced by antiepidermal growth factor receptor agents: a systematic review and meta-analysis.

Relationship between skin rash and outcome in non-small-cell lung cancer patients treated with anti-EGFR tyrosine kinase inhibitors: a literature-based meta-analysis of 24 trials.

The predictive role of skin rash with cetuximab and panitumumab in colorectal cancer patients: a systematic review and meta-analysis of published trials.

Management of epidermal growth factor receptor inhibitor-associated rash: a systematic review.

Management of Skin Reactions During Cetuximab Treatment in Association With Chemotherapy or Radiotherapy: Update of the Italian Expert Recommendations.

Epidermal EGFR controls cutaneous host defense and prevents inflammation.

Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced Skin Toxicities in Patients With Metastatic Lung Cancer.

P304

312

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/ATM.2016.07.01

http://www.w3.org/2001/XMLSchema#string

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27668232

http://www.w3.org/2001/XMLSchema#string

P932

5009023

http://www.w3.org/2001/XMLSchema#string